A general overview of efficacy and safety data for current treatment options for patients with chronic lymphocytic leukemia.

Adding chemotherapy did not improve outcomes for patients with endometrial cancer that recurred in the pelvic region. Radiation alone was found to be ...

The Food and Drug Administration (FDA) approved Breyanzi (lisocabtagene maraleucel) for the treatment of patients with relapsed or refractory follicular ...

Common side effects after receiving IMRT include worsened urinary and bowel function in patients with prostate cancer. Intensity-modulated radiation therapy ...

I didn’t know I did this, but recently I’ve become aware that I tend to change things about myself that I don’t think are valued. It seems to happen ...

Cancer-related fatigue is so common that between 80% and 100% of people with cancer report fatigue as a side effect, according to the American Cancer ...

What motivated you to set that up? I am fortunate enough to have a brilliant colleague in the school of infection and immunity at the University of ...

Focusing on acalabrutinib-based treatment, Yuliya Linhares, MD, discusses results from the ELEVATE TN clinical trial.

Proteins linked to cancer can start appearing in people’s blood more than seven years before they’re diagnosed, our funded researchers have found. In ...

Having a professional support system can be important after receiving a diagnosis of metastatic breast cancer.Receiving a diagnosis of metastatic breast ...